Inzy stock forecast.

The company’s stock had a trading volume of 1,882,507 shares, compared to its average volume of 1,653,219. The company’s fifty day simple moving average is $55.35 and its 200-day simple moving ...

Inzy stock forecast. Things To Know About Inzy stock forecast.

Earnings Date. Feb 05, 2024 - Feb 09, 2024. Forward Dividend & Yield. N/A (N/A) Ex-Dividend Date. N/A. 1y Target Est. 74.41. Fair Value is the appropriate price for the shares of a company, based ...According to our current INZY stock forecast, the value of Inozyme Pharma shares will rise by 7.27% and reach $ 3.50 per share by November 24, 2023. According to our technical indicators, the current sentiment is Bearish while the Fear & Greed Index is showing 39 (Fear). Analyzing the anticipated performance of Incyte, the ceiling value that the stock is expected to reach in 2025 stands at a promising $79.7.Indicating a bullish trend, an upside potential of 40.27% signals profitable prospects, with an average monthly return of 1.55%, beckoning investors to consider amplifying their portfolios.Which executives are buying and selling shares of Inozyme Pharma stock? View the latest INZY insider trading activity at MarketBeat. Skip to main content. S&P 500 4,594.63. DOW 36,245.50. QQQ 389.94. Closing prices for crude oil, gold and other commodities. ... Advanced Stock Screeners and Research Tools.

Dec 1, 2023 · Earnings for Incyte are expected to grow by 28.00% in the coming year, from $3.00 to $3.84 per share. Incyte has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 6th, 2024 based off prior year's report dates. Read More. Find the latest Eos Energy Enterprises, Inc. (EOSE) stock quote, history, news and other vital information to help you with your stock trading and investing.

President exercised options and sold US$65k worth of stock Jun 26. Inozyme Pharma, Inc. Announces Acceptance of First European Clinical Trial Application …Inozyme Pharma Inc. 3.23. Delayed Data. As of Nov 16. +0.03 / +0.94%. Today’s Change. 0.99. Today ||| 52-Week Range. 7.33.

What this means: Inozyme Pharma Inc (INZY) gets an Overall Rank of 67, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. Gas prices are at a record high, and experts are forecasting that prices could go higher this summer — perhaps $5 or even over $6 a gallon. By clicking "TRY IT", I agree to receive newsletters and promotions from Money and its partners. I a...Overview Stock Screener Earnings Calendar Sectors Nasdaq | INZY U.S.: Nasdaq Inozyme Pharma Inc. Watch list NEW Set a price target alert Open Last Updated: Oct 12, 2023 …With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.Inozyme Pharma Stock Chart and Share Price Forecast, Short-Term "INZY" Stock Prediction for Next Days and Weeks Walletinvestor.com Inozyme Pharma Inc (INZY) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024

Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level. Try it Free. Find the latest Incyte Corporation (INCY) stock forecast based ...

Read Full Company Summary for INCY here. View Incyte Corporation INCY investment & stock information. Get the latest Incyte Corporation INCY detailed stock quotes, stock data, Real-Time ECN ...

But that wasn’t the same sentiment insiders shared. CEO Malhotra and Director Robert Jordan collectively nabbed roughly $100,000 worth of TCS stock at average prices ranging from $2.569 to $2.63. Malhotra accounted for most of the buying, with more than 29,000 shares purchased, totaling around $76,000.What this means: Inozyme Pharma Inc (INZY) gets an Overall Rank of 67, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value.Find the latest Bullfrog AI Holdings, Inc. (BFRG) stock quote, history, news and other vital information to help you with your stock trading and investing.Target values for the price of one Incyte share for Jan 2025. The weighted average target price per Incyte share in Jan 2025 is: 59.50. In Jan, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 7.054% volatility is expected. Pessimistic target level: 56.44. Optimistic target level: 60.73.On December 4, 2023, Incyte (NASDAQ:INCY) received a significant boost as Guggenheim analyst Michael Schmidt upgraded the company’s rating from Neutral to Buy. Schmidt set a price target of $86.00 for the stock, indicating a positive outlook on Incyte’s performance. This upgrade aligns with the consensus among analysts, who have an average rating of …

Find the latest Fangdd Network Group Ltd. (DUO) stock quote, history, news and other vital information to help you with your stock trading and investing.Inozyme Pharma, Inc. Common Stock (INZY) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Price Prediction Incyte price predictions from 2023 to 2027. Gain insights into monthly forecasts, trends, and analyses to make informed investment decisions.The Incyte Corp. stock forecast for tomorrow is $ 53.83, which would represent a 0.02% gain compared to the current price. In the next week, the price of INCY is expected to increase by 4.07% and hit $ 56.01. As far as the long-term Incyte Corp. stock forecast is concerned, here’s what our predictions are currently suggesting.Get the latest Inozyme Pharma Inc (INZY) stock quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. See the company's financial results, market news, and earnings per share for the fiscal Q2 2023 ended 6/30/23.Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.

Find the latest Eargo, Inc. (EAR) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest Incyte Corporation (INCY) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance

Find the latest Dogecoin USD (DOGE-USD) price quote, history, news and other vital information to help you with your cryptocurrency trading and investing.Find the latest Incyte Corporation (INCY) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance4 Wall Street research analysts have issued 12 month price targets for Argo Blockchain's stock. Their ARBK share price targets range from $1.45 to $2.75. On average, they expect the company's stock price to reach $2.23 in the next twelve months. This suggests a possible upside of 90.9% from the stock's current price.If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...Aug 9, 2023 · For the current quarter, INZY is expected to report an EPS forecast of -$0.45. In terms of annual financials, INZY reported an annual revenue of $0.00 for the last year and an annual profit of -$67.1 million. INZY Stock Shows Promising Performance on August 9, 2023: Optimistic Price Forecasts and Unanimous Buy Rating. INZY stock, belonging to ... The stock market is poised to "zig-zag" towards record highs in December, with the S&P 500 rising 5% to 4,800, according to a Monday note from Fundstrat's Tom …Find the latest Gaotu Techedu Inc. (GOTU) stock quote, history, news and other vital information to help you with your stock trading and investing.Inozyme Pharma Inc. 3.23. Delayed Data. As of Nov 16. +0.03 / +0.94%. Today’s Change. 0.99. Today ||| 52-Week Range. 7.33. In today’s fast-paced business environment, accurate forecasting is crucial for making informed decisions and staying ahead of the competition. One powerful tool that can help you achieve this is a forecasting Excel template.

Inozyme Pharma Stock Forecast and Price Target. The average price target for Inozyme Pharma's stock set by recognized analysts recently is $23.00, which would result in a potential upside of approximately 701.39% if it reached this mark. The estimation is based on a high estimate of $40.00 and a low estimate of $5.00.

10 Stocks With Huge Catalysts on the Way. In this article, we will take a look at the 10 stocks with huge catalysts on the way. To see more such companies, go directly to 5 Stocks With Huge Catalysts on the Way. The US stock market continues to be in a see-saw mode as investors gauge and digest latest data. The latest jobs […] Yahoo | October ...

Is Inozyme Pharma Stock Undervalued? The current Inozyme Pharma share price is $3.85. The Score for INZY is 44, which is 12% below its historic median score of 50, and infers higher risk than normal. INZY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.Price Prediction Incyte price predictions from 2023 to 2027. Gain insights into monthly forecasts, trends, and analyses to make informed investment decisions.Nasdaq Futures 16,054.50 +30.75(+0.19%) Russell 2000 Futures 1,807.30 +1.50(+0.08%) Crude Oil 77.85 -0.01(-0.01%) Gold 2,065.80 -1.30(-0.06%) Inozyme Pharma, Inc. (INZY) …Find the latest Cabaletta Bio, Inc. (CABA) stock quote, history, news and other vital information to help you with your stock trading and investing.A high-level overview of Inozyme Pharma, Inc. (INZY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.The stock price for . Inozyme Pharma (NASDAQ: INZY) is $3.205 last updated Today at November 16, 2023 at 6:59 PM UTC. Q Does Inozyme Pharma (INZY) pay a dividend?Is Inozyme Pharma Stock Undervalued? The current Inozyme Pharma share price is $3.85. The Score for INZY is 44, which is 12% below its historic median score of 50, and infers higher risk than normal. INZY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.Dec 1, 2023 · 19 Wall Street analysts have issued 1-year price objectives for Incyte's stock. Their INCY share price targets range from $61.00 to $100.00. On average, they expect the company's share price to reach $79.94 in the next year. This suggests a possible upside of 48.0% from the stock's current price. Find the latest Summit Therapeutics Inc. (SMMT) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest Vyant Bio, Inc. (VYNT) stock quote, history, news and other vital information to help you with your stock trading and investing.

Incyte Corp. Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development and commercialization of proprietary therapeutics. Its portfolio includes compounds in various stages, ranging from preclinical to late stage development, and commercialized products such as JAKAFI (ruxolitinib), and ICLUSIG (ponatinib). Click here to know why INCY stock is a buy. Incyte's core business looks solid. Opzelura's sales start is impressive, but revenue is low due to high discounts. ... 2022 forecast. According to ...Sep 20, 2023 · Inozyme Pharma, Inc. (INZY) share price prediction for 2023, 2024, 2025, 2026 and 2027. INZY one year forecast. Inozyme Pharma stock monthly and weekly forecasts. Instagram:https://instagram. what stock is good to buy nowinteractive brokers vs tradestationwhen does pre order start for iphone 15best books for beginner traders Find the latest SciSparc Ltd. (SPRC) stock quote, history, news and other vital information to help you with your stock trading and investing.Nov 1, 2023 · Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level. Try it Free. Find the latest Incyte Corporation (INCY) stock forecast based ... currency etfs listsetting up a real estate investment company Find the latest Pyxis Oncology, Inc. (PYXS) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest Incyte Corporation (INCY) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance jmbs 16 analysts have issued twelve-month price objectives for Alibaba Group's shares. Their BABA share price targets range from $90.00 to $150.00. On average, they expect the company's share price to reach $129.20 in the next year. This suggests a possible upside of 74.6% from the stock's current price.The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility ...Agile Therapeutics, Inc. (NASDAQ:AGRX) Q3 2023 Earnings Call Transcript November 9, 2023 Agile Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.27, expectations were $-1.58.